Skip to content
MATR
  • Home
  • Events
  • Jobs
  • Sponsors
  • Supporters
  • About Us
    • Our Mission
    • Become A MATR Sponsor
    • Contact
    • Newsletter Archives
The state with the best education wins!
  • Register/Sign Up
  • Log In
MATR
  • Home
  • Events
  • Jobs
  • Sponsors
  • Supporters
  • About Us
    • Our Mission
    • Become A MATR Sponsor
    • Contact
    • Newsletter Archives

News

First sleep apnea drug reduces severity in 70% of trial cases

March 18, 2024/No Comments

“Those who had a physiological improvement in their airway function during sleep also had between 25–45% reductions in markers of their OSA severity, including improved oxygen levels as well as a reduction in their blood pressure the next day.”

By Paul McClure


Click here to read the story.

Related Stories

  1. Wearable treats pain and depression in as little as one 40-minute session
  2. Fitbit data accurately predicts bipolar disorder mood swings

Leave a Comment Cancel Reply

You must be logged in to post a comment.

MATR Sponsor (view all)


Working to create a clean and balanced energy portfolio that will provide for a safe and reliable energy future. Learn more at http://www.NorthWesternEnergy.com/BrightFuture

MATR Supporters (view all)


We will bring the North Coast Hiawatha train route back to Southern Montana

ADROIT Employer Resources is a Montana-based workforce and talent solutions partner

Working closely with GFDA’s economic development team, HPF helps Montana businesses access the capital they need to expand, modernize, and strengthen local communities.

© 2026 MATR. All Rights Reserved.

Proudly Powered and Sponsored by:

Privacy Policy

15585

The best in Montana tech news

Get the most useful news and opportunities in tech twice a week, all for free.

15856